Condition
Primary Open Angle Glaucoma clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Primary Open Angle Glaucoma clinical trials that are recruiting, at sites in 14 countries (most in United States (7), Germany (4), Austria (3)). By phase: Phase 2 (1), Phase 3 (1). The most active sponsors are Nova Eye, Inc. (2), Cairo University (2). There are also 7 NIH-funded research projects on Primary Open Angle Glaucoma, with $3.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 7NIH research projects
- 14Countries
Newest Primary Open Angle Glaucoma clinical trials
All recruiting trials (18)
-
G01 Eye Drops for Glaucomatous Optic Neuropathy
This trial tests whether G01 Eye Drops can help people with open-angle glaucoma who also have optic nerve injury.
-
Additive Physical Activity for Hypothyroidism in Older Women with Glaucoma and Fatty Liver
We’re testing whether adding a treadmill-based exercise program to standard thyroid treatment helps improve health in older women who have subclinical hypothyroidism, glaucoma, and fatty liver.
-
Lifestyle changes plus nightly CPAP for glaucoma in people with sleep apnea
This test checks whether adding a low-calorie diet and regular walking to nightly CPAP lowers eye pressure in people with high‑pressure open‑angle glaucoma who also have obstructive sleep apnea and obesity.
-
Direct Selective Laser Trabeculoplasty to reduce glaucoma medications
This study will try Direct Selective Laser Trabeculoplasty (DSLT) to reduce the number of eye-drop medications in adults with medically controlled primary open-angle glaucoma or ocular hypertension.
-
Hexiris MIST device to lower eye pressure in people with primary open-angle glaucoma
This trial will test the Hexiris MIST device to see if it lowers eye pressure in adults 40 and older whose primary open-angle glaucoma isn’t controlled by eye drops.
-
PRESERFLO MicroShunt XI: patient experience follow-up after implantation for open-angle glaucoma
A single-arm, post-market follow-up study to see how the PRESERFLO MicroShunt XI performs and whether it remains safe in adults with primary open angle glaucoma who aren’t controlled on medications.
-
Direct selective laser trabeculoplasty to lower eye pressure in untreated open-angle glaucoma
This study will try direct selective laser trabeculoplasty (DSLT) to lower eye pressure by more than 20% without glaucoma medications over six months in adults newly diagnosed with open-angle glaucoma or ocular hypertension.
-
Assessing the safety and effectiveness of a glaucoma gel stent implantation
This study is testing a new gel stent for treating glaucoma to see if it works well and is safe for people over 45 who haven't had success with other treatments.
-
Electrical stimulation treatment for visual field defects in glaucoma patients
This study is testing if a new electrical stimulation treatment can help people with glaucoma keep their vision from getting worse while they continue using their regular eye drops.
-
Home IOP telemonitoring with smartphone support for open-angle glaucoma
This trial tests whether home intraocular pressure monitoring plus a smartphone-based management plan helps people with newly diagnosed open-angle glaucoma control eye pressure better than a smartphone-based plan alone.
-
Nanodropper microdrop delivery for primary open-angle glaucoma and ocular hypertension
This test will see if Nanodropper microdrops of glaucoma medicines lower eye pressure as well as standard eye drops for adults with primary open-angle glaucoma or ocular hypertension.
-
Evaluating standalone canaloplasty for glaucoma treatment
This study is testing two different devices for a procedure called canaloplasty to see which one works better for people with mild to moderate glaucoma.
-
Cataract surgery combined with canaloplasty for glaucoma patients
This study is testing whether combining cataract surgery with a special glaucoma procedure can help people with mild to moderate glaucoma manage their eye pressure better than just cataract surgery alone.
-
Comparing XEN Glaucoma Gel Stent and Trabeculectomy for Glaucoma Treatment
This study is testing whether a new minimally invasive glaucoma implant works better than traditional surgery for improving vision in people with open angle glaucoma.
-
Assessing the Glycocalyx in Patients with Primary Open-angle Glaucoma
This study is testing a special imaging technique to see if the tiny blood vessels in people with primary open-angle glaucoma are working properly compared to those without eye problems.
-
Evaluation of Hydrus Microstent after cataract surgery for glaucoma
This study is testing how well the Hydrus Microstent works for people with glaucoma after they have cataract surgery to see if it stays in place and improves their eye health over two years.
-
Measuring retinal photoreceptor response to light stimulation
This study is testing a new way to measure how light affects the eye's photoreceptors in healthy people and those with glaucoma or age-related macular degeneration to see if it can help track eye health.
-
Diagnostic innovations for detecting glaucoma in eyes with and without myopia
This project tests imaging and vision tests to see if they can better detect glaucoma or its worsening in adults with or without myopia.
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Improving glaucoma risk predictions using diverse genetic data
A glaucoma study uses genetic data from people of African, American, and European ancestry to build better risk scores and help with early detection.
-
Multimodal AI to predict glaucoma progression and guide care
A big-data AI tool uses eye images, scans, field tests, and health info to help predict who with open-angle glaucoma is at higher risk of vision loss so doctors can act sooner.
-
Replacing damaged eye drainage cells to treat glaucoma
This project is developing a cell-based treatment to replace lost drainage cells and help people with primary open-angle glaucoma keep eye pressure lower and protect vision.
-
Improving risk prediction for glaucoma in diverse populations
This study is looking to improve how we predict the risk of primary open-angle glaucoma in people of African ancestry, so that they can get better early diagnosis and treatment options based on their unique genetic background.
-
Using cell therapy to treat primary open angle glaucoma
This study is testing a new cell therapy to help people with primary open angle glaucoma by using special stem cells to improve eye function and lower pressure, which could help prevent vision loss when regular treatments aren't enough.
-
Better genetic risk prediction for open-angle glaucoma
This project will build more accurate genetic risk tools for people at risk of open-angle glaucoma by including more diverse ancestry groups in the analysis.
-
Improving fairness in glaucoma risk estimation using artificial intelligence
This study is working on a new AI tool to help better predict the risk of glaucoma, especially for people in diverse communities like African and Hispanic Americans, so that everyone can get fairer and more accurate eye care.
Related topics
Quick answers
How many Primary Open Angle Glaucoma clinical trials are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (7 trials), Germany (4 trials), Austria (3 trials), Spain (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.